Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b studyJames J. Harding, Sebastián Mondaca, Jin Won Kim et al.|The Lancet Oncology|2023Cited by 243
Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expressionHye Jin Choi, Hong Seok Choi|British Journal of Pharmacology|2015Cited by 53